SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-047717
Filing Date
2021-02-18
Accepted
2021-02-18 16:15:51
Documents
2
Group Members
CHRISTIAN ANGERMAYERPRESIGHT CO-INVEST FUND, L.P.PRESIGHT SENSEI CO-INVEST MANAGEMENT, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G d143453dsc13g.htm SC 13G 89900
2 EX-99 d143453dex99.htm EX-99 6006
  Complete submission text file 0001193125-21-047717.txt   97568
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92222 | Film No.: 21649686
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13G